Neilson Laura Jane, Fitzgerald Rebecca C, Deane Jennifer, Debiram-Beecham Irene, Gulle Halime, Rees Colin, Sharp Linda
Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Department of Gastroenterology, South Tyneside District Hospital, South Shields, UK.
Frontline Gastroenterol. 2023 Sep 11;15(1):28-34. doi: 10.1136/flgastro-2023-102484. eCollection 2024 Jan.
Cytosponge is a novel technology for oesophageal pathology diagnosis. Uses include diagnosis of Barrett's oesophagus and as a triage tool to prioritise upper gastrointestinal endoscopy. Patient experience is a key component of quality care. Previous work has developed endoscopy patient-reported experience measures. An appropriate tool to measure patient experience of Cytosponge is required. The aim of this work was to describe the patient experience of Cytosponge.
DESIGN/METHOD: Individuals aged 18 years or over, who had undergone Cytosponge from September 2020 to March 2021, were invited to participate in a semi-structured interview. Interviews were audio-recorded, transcribed verbatim and anonymised. Thematic analysis was undertaken. Themes were organised into two overarching areas relating to patient experiences and patient perceptions of the test.
19 patients underwent interview (aged 37-80 years, 13 male). In terms of patient experiences of Cytosponge, five themes were identified: emotional reaction; expectations; environment and physical process; sensory experience; communication and information. All themes were present across all procedural phases, aside from sensory experience which was only present during the test. With regard to perception of the test, two major themes were identified: test novelty (encompassing patient awareness of the test and reaction to the new test) and trusting the test results.
Patients must remain central to novel technologies such as Cytosponge. Measuring patient experience is essential to achieve that. This study demonstrates five major themes which describe the patient experience of this procedure. These have been used to adapt the Newcastle ENDOPREM for use in Cytosponge.
细胞海绵是一种用于食管病理学诊断的新技术。其用途包括诊断巴雷特食管以及作为对上消化道内镜检查进行优先排序的分诊工具。患者体验是优质护理的关键组成部分。先前的工作已开发出内镜检查患者报告的体验指标。需要一种合适的工具来衡量患者对细胞海绵的体验。这项工作的目的是描述细胞海绵的患者体验。
设计/方法:邀请了2020年9月至2021年3月期间接受过细胞海绵检查的18岁及以上个体参加半结构化访谈。访谈进行了录音、逐字转录并匿名处理。进行了主题分析。主题被组织成与患者体验和患者对该检查的认知相关的两个总体领域。
19名患者接受了访谈(年龄37 - 80岁,13名男性)。在细胞海绵的患者体验方面,确定了五个主题:情绪反应;期望;环境与身体过程;感官体验;沟通与信息。除感官体验仅在检查期间出现外,所有主题在所有程序阶段均有体现。关于对该检查的认知,确定了两个主要主题:检查的新颖性(包括患者对该检查的知晓度以及对新检查的反应)和对检查结果的信任。
患者必须始终是细胞海绵等新技术的核心。衡量患者体验对于实现这一点至关重要。本研究展示了描述该程序患者体验的五个主要主题。这些已被用于调整纽卡斯尔内镜检查患者体验量表以用于细胞海绵检查。